Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Canadian Cardiovascular Congress 2006
Reducing Lifetime Cardiovascular Disease Event Rates: Emphasizing Early Risk Factor Modification and Intensive Intervention
Vancouver, British Columbia / October 21-25, 2006
Vancouver - Atherosclerosis typically begins between 10 and 20 years of age, with clinical manifestations developing at approximately 50 years of age. Early intensive risk factor modification aimed at altering the course of cardiovascular...
Canadian Cardiovascular Congress 2006
Advances in the Treatment of Heart Failure
Vancouver, British Columbia / October 21-25, 2006
Vancouver - Updated guidelines on heart failure diagnosis and management are aimed at disseminating current evidence to specialists and translating that knowledge to other practitioners involved in the care of patients with this...
Canadian Cardiovascular Congress 2006
Raising the Lipid Bar: Attaining the New Canadian Guideline Levels
Vancouver, British Columbia / October 21-25, 2006
Vancouver - New Canadian lipid guidelines have set targets for LDL-C at <2.0 mmol/L and a total cholesterol:HDL-C (TC:HDL) ratio of <4. To achieve these targets, the guidelines recommend titration of the initial statin up to its...
Canadian Cardiovascular Congress 2006
Assessing Individual Cardiovascular Disease Risk and Implementing Timely Intervention
Vancouver, British Columbia / October 21-25, 2006
Vancouver - Assessing patient risk is critical in the management of cardiovascular disease (CVD), especially for those at highest risk who benefit the most from proven strategies. One important risk factor often neglected is the estimated...
Canadian Cardiovascular Congress 2006
New Guidelines for Lipids: Clinical and Biological Evidence
Vancouver, British Columbia / October 21-25, 2006
Vancouver - New Canadian guidelines on dyslipidemia diagnosis and treatment were emphasized in many sessions here at the CCC. The intervention point for low-risk individuals in LDL-C levels is now 5 mmol/L or a total cholesterol:HDL-C ratio...
Canadian Cardiovascular Congress 2006
Advances in the Treatment of Heart Failure
Vancouver, British Columbia / October 21-25, 2006
Vancouver - Updated guidelines on heart failure diagnosis and management are aimed at disseminating current evidence to specialists and translating that knowledge to other practitioners involved in the care of patients with this...
Canadian Cardiovascular Congress 2006
Reducing Stroke Through RAS Inhibition: Benefits and Mechanisms
Vancouver, British Columbia / October 21-25, 2006
Vancouver - The control of hypertension has a well-established positive impact on the risk of stroke. Whether one or more antihypertensive agents may be particularly beneficial for reducing stroke incidence is unclear. As discussed here...
21st Scientific Meeting of the International Society of Hypertension
Reducing 10-year Mortality and Overall Cardiovascular Risk with Single-pill Combination
Fukuoka, Japan / October 15-19, 2006
Fukuoka - Hypertension and dyslipidemia are two key risk factors in the development of cardiovascular disease. Targeting both risk factors with a single tablet combination has the potential to simplify overall cardiovascular risk...
World Congress of Cardiology 2006
Direct Renin Inhibition: Upstream blocking of the Renin-Angiotensin System in Hypertension
Barcelona, Spain / September 2-6, 2006
INTRODUCTION In Canada, data from the 1990s indicated that approximately 17% of hypertensive patients had their blood pressure (BP) adequately controlled, ahead of BP control rates in Europe but behind US rates. However, we know that...